Doctors at San Francisco General Hospital's famed AIDS clinic have shown the immune system can be primed to keep the virus in ...

More than half of organisations providing HIV care surveyed by International Planned Parenthood Federation said they had run out of stock at some point during past 12 months ...

A new study from the London School of Economics and Political Science (LSE) and Duke University, published in The Lancet ...

Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.

HIV prevention looks very different than it did a generation ago. Today, people have more tools than ever to protect themselves, from condoms and routine testing to PrEP, a medication that can ...

Nearly 100 community-based organizations have lost their federal HIV-prevention grants this week as the Trump administration redirects dollars to state and local health departments. The funding ...

For people living with HIV, the road to a promising cancer treatment can be longer than it should be, literally.

September, Fiji's government declared a national emergency because of a startling rise in HIV infections. The country's ...

Lung cancer screening eligibility increased markedly from 2018–2023 under USPSTF criteria, reflecting aging and substantial ...

Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...

Ahmed is a postdoc researcher at Perelman School of Medicine, University of Pennsylvania. Taylor is director of the HIV+Aging Research Project-Palm Springs and a long-term survivor of HIV. Berry is ...

In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...